AU2013213769A1 - Gastroretentive tablets - Google Patents

Gastroretentive tablets

Info

Publication number
AU2013213769A1
AU2013213769A1 AU2013213769A AU2013213769A AU2013213769A1 AU 2013213769 A1 AU2013213769 A1 AU 2013213769A1 AU 2013213769 A AU2013213769 A AU 2013213769A AU 2013213769 A AU2013213769 A AU 2013213769A AU 2013213769 A1 AU2013213769 A1 AU 2013213769A1
Authority
AU
Australia
Prior art keywords
pregabalin
gastroretentive
pharmaceutically acceptable
gas generating
acceptable excipients
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2013213769A
Other languages
English (en)
Inventor
Shavej AHMAD
Varinder Kumar
Romi Barat Singh
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sun Pharmaceutical Industries Ltd
Original Assignee
Ranbaxy Laboratories Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=48014113&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=AU2013213769(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Ranbaxy Laboratories Ltd filed Critical Ranbaxy Laboratories Ltd
Publication of AU2013213769A1 publication Critical patent/AU2013213769A1/en
Assigned to SUN PHARMACEUTICAL INDUSTRIES LIMITED reassignment SUN PHARMACEUTICAL INDUSTRIES LIMITED Amend patent request/document other than specification (104) Assignors: RANBAXY LABORATORIES LIMITED
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0065—Forms with gastric retention, e.g. floating on gastric juice, adhering to gastric mucosa, expanding to prevent passage through the pylorus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Inorganic Chemistry (AREA)
  • Physiology (AREA)
  • Nutrition Science (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AU2013213769A 2012-01-30 2013-01-29 Gastroretentive tablets Abandoned AU2013213769A1 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
IN250DE2012 2012-01-30
IN252DE2012 2012-01-30
IN250/DEL/2012 2012-01-30
IN252/DEL/2012 2012-01-30
PCT/IB2013/050764 WO2013114283A1 (en) 2012-01-30 2013-01-29 Gastroretentive tablets

Publications (1)

Publication Number Publication Date
AU2013213769A1 true AU2013213769A1 (en) 2014-08-21

Family

ID=48014113

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2013213769A Abandoned AU2013213769A1 (en) 2012-01-30 2013-01-29 Gastroretentive tablets

Country Status (7)

Country Link
US (1) US9393205B2 (enExample)
EP (1) EP2809304A1 (enExample)
AU (1) AU2013213769A1 (enExample)
CA (1) CA2863376A1 (enExample)
IN (1) IN2014DN06966A (enExample)
WO (1) WO2013114283A1 (enExample)
ZA (1) ZA201405581B (enExample)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110974798A (zh) * 2019-12-19 2020-04-10 江苏优仿医药科技有限公司 药物组合物、缓释片剂及其制备方法

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2809303A1 (en) * 2012-01-30 2014-12-10 Ranbaxy Laboratories Limited Pregabalin gr tablets
EP3099288A1 (en) * 2014-01-28 2016-12-07 Sun Pharmaceutical Industries Ltd Stabilized gastroretentive tablets of pregabalin
WO2015174684A1 (ko) * 2014-05-14 2015-11-19 동아에스티 주식회사 방출제어된 위체류 서방성 제제
EP3498260A1 (en) * 2017-12-12 2019-06-19 Pro.Med.CS Praha A.S. Oral gastroretentive sustained-release pharmaceutical formulation
JP2019167333A (ja) * 2018-03-22 2019-10-03 日東電工株式会社 プレガバリン含有組成物の製造方法およびプレガバリン含有組成物
CN111053749B (zh) * 2018-10-16 2022-07-15 北京泰德制药股份有限公司 一种普瑞巴林缓释组合物及其制备方法
CN111741748B (zh) 2018-06-13 2022-09-23 北京泰德制药股份有限公司 一种普瑞巴林缓释组合物及其制备方法
CN114796142A (zh) * 2022-04-08 2022-07-29 黄山学院 萘普生胃漂浮片及其制备方法
GB2624861A (en) * 2022-11-28 2024-06-05 Orbit Pharma Ltd Sustained release pharmaceutical compositions comprising pregabalin or pharmaceutically acceptable salts thereof

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6197819B1 (en) 1990-11-27 2001-03-06 Northwestern University Gamma amino butyric acid analogs and optical isomers
KR100491282B1 (ko) 1996-07-24 2005-05-24 워너-램버트 캄파니 엘엘씨 통증 치료용 이소부틸가바 및 그의 유도체
NL2000281C2 (nl) 2005-11-02 2007-08-07 Pfizer Prod Inc Vaste farmaceutische samenstellingen die pregabaline bevatten.
US8454993B2 (en) 2007-11-23 2013-06-04 Lupin Limited Controlled release pharmaceutical compositions of pregabalin
RU2012100709A (ru) 2009-06-12 2013-07-20 Майкро Лэбз Лимитед Новые фармацевтические композиции, содержащие прегабалин
IN2012MN02923A (enExample) 2010-06-01 2015-06-05 Rubicon Res Private Ltd

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110974798A (zh) * 2019-12-19 2020-04-10 江苏优仿医药科技有限公司 药物组合物、缓释片剂及其制备方法

Also Published As

Publication number Publication date
ZA201405581B (en) 2015-06-24
CA2863376A1 (en) 2013-08-08
WO2013114283A1 (en) 2013-08-08
EP2809304A1 (en) 2014-12-10
IN2014DN06966A (enExample) 2015-04-10
US9393205B2 (en) 2016-07-19
US20150025146A1 (en) 2015-01-22

Similar Documents

Publication Publication Date Title
US9393205B2 (en) Gastroretentive tablets
US9289392B2 (en) Extended release pharmaceutical composition of entacapone or salts thereof
JP5816091B2 (ja) ナトリウムオキシベートの即時放出投薬形態
KR102221846B1 (ko) 안정성이 개선된 프레가발린을 함유하는 약제학적 조성물 및 이의 제조방법
US20140378545A1 (en) Pregabalin gr tablets
EP3131533A1 (en) Oral dosage form of ketamine
US10258584B2 (en) Pregabalin sustained-release preparation
US20050158380A1 (en) Sustained release oral dosage forms of gabapentin
CN104840443B (zh) 含活性成分普瑞巴林的药物组合物
JP2011241218A (ja) ｐＨ非依存延長放出性医薬組成物
US20200330433A1 (en) Extended release pharmaceutical composition of apremilast
US20110229566A1 (en) Single Unit Oral Dose Pharmaceutical Composition Comprising Levodopa, Carbidopa And Entacapone Or Salts Thereof
EP1496868A1 (en) Controlled release pharmaceutical compositions of carbidopa and levodopa
EP2801350B1 (en) Pharmaceutical Formulations of Lacosamide
CN114246836B (zh) 一种普瑞巴林缓释片及其制备方法
WO2015114656A2 (en) Mucoadhesive tablet of pregabalin
WO2007121537A1 (en) Controlled release formulations comprising uncoated discrete unit(s) and an extended release matrix
EP2929878A1 (en) Extended release formulations of gabapentin
US20070160667A1 (en) Controlled release formulation of divalproex sodium
JP2009525953A (ja) ジバルプロ酸及びその誘導体の徐放性製剤
WO2015114655A2 (en) Modified release tablet of pregabalin
US20160338949A1 (en) Stabilized gastroretentive tablets of pregabalin
WO2013109205A1 (en) Pharmaceutical tablet formulations comprising cefetamet
WO2011107922A2 (en) Extended release composition of milnacipran

Legal Events

Date Code Title Description
MK5 Application lapsed section 142(2)(e) - patent request and compl. specification not accepted